BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1991379)

  • 1. Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model.
    Dorian P; Wang M; David I; Feindel C
    Circulation; 1991 Feb; 83(2):614-21. PubMed ID: 1991379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.
    Echt DS; Black JN; Barbey JT; Coxe DR; Cato E
    Circulation; 1989 May; 79(5):1106-17. PubMed ID: 2469545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of flecainide, encainide, and clofilium on ventricular refractory period extension by transcardiac shocks.
    Sweeney RJ; Gill RM; Steinberg MI; Reid PR
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):50-60. PubMed ID: 8848377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barium decreases defibrillation energy requirements.
    Dorian P; Witkowski FX; Penkoske PA; Feder-Elituv RS
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):107-12. PubMed ID: 7511721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of encainide and its metabolites on energy requirements for defibrillation.
    Fain ES; Dorian P; Davy JM; Kates RE; Winkle RA
    Circulation; 1986 Jun; 73(6):1334-41. PubMed ID: 3084128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of newer antiarrhythmic drugs on defibrillation threshold.
    Tacker WA; Niebauer MJ; Babbs CF; Combs WJ; Hahn BM; Barker MA; Seipel JF; Bourland JD; Geddes LA
    Crit Care Med; 1980 Mar; 8(3):177-80. PubMed ID: 7363635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DL and D sotalol decrease defibrillation energy requirements.
    Wang M; Dorian P
    Pacing Clin Electrophysiol; 1989 Sep; 12(9):1522-9. PubMed ID: 2476781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-pulse defibrillation using pulse separation based on the fibrillation cycle length.
    Sweeney RJ; Gill RM; Reid PR
    J Cardiovasc Electrophysiol; 1994 Sep; 5(9):761-70. PubMed ID: 7827715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tedisamil increases coherence during ventricular fibrillation and decreases defibrillation energy requirements.
    Dorian P; Newman D
    Cardiovasc Res; 1997 Feb; 33(2):485-94. PubMed ID: 9074714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the "defibrillation threshold" concept.
    Davy JM; Fain ES; Dorian P; Winkle RA
    Am Heart J; 1987 Jan; 113(1):77-84. PubMed ID: 3799444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success rate versus defibrillation energy: temporal profile and the most efficient defibrillation threshold.
    Murakawa Y; Gliner BE; Thakor NV
    Am Heart J; 1989 Sep; 118(3):451-8. PubMed ID: 2773769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models.
    Kopia GA; Eller BT; Patterson E; Shea MJ; Lucchesi BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):49-61. PubMed ID: 4054216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chronic oral and acute intravenous amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs.
    Frame LH
    Pacing Clin Electrophysiol; 1989 Feb; 12(2):339-46. PubMed ID: 2468144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations.
    Fotuhi PC; Ideker RE; Idriss SF; Callihan RL; Walker RG; Alt EU
    Circulation; 1995 Nov; 92(10):3082-8. PubMed ID: 7586279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of normothermic and hypothermic cardiopulmonary bypass on defibrillation energy requirements and transmyocardial impedance. Implications for implantable cardioverter-defibrillator implantation.
    Martin D; Garcia J; Valeri CR; Khuri SF
    J Thorac Cardiovasc Surg; 1995 May; 109(5):981-8. PubMed ID: 7739260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms.
    Dixon EG; Tang AS; Wolf PD; Meador JT; Fine MJ; Calfee RV; Ideker RE
    Circulation; 1987 Nov; 76(5):1176-84. PubMed ID: 3665001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of quinidine and bretylium on defibrillation energy requirements.
    Dorian P; Fain ES; Davy JM; Winkle RA
    Am Heart J; 1986 Jul; 112(1):19-25. PubMed ID: 3728282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The defibrillation threshold: a comparison of anesthetics and measurement methods.
    Gill RM; Sweeney RJ; Reid PR
    Pacing Clin Electrophysiol; 1993 Apr; 16(4 Pt 1):708-14. PubMed ID: 7683796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional transvenous/subcutaneous defibrillation of ventricular fibrillation in dogs: success rates, energy requirements, currents, voltages and impedance.
    Budde T; Vukmirovic NB; Soriano-Romero JM; Abu-Ghazaleh S; Borggrefe M; Schmiel FK; Pölitz B; Arnold G; Breithardt G
    Eur Heart J; 1988 Jan; 9(1):92-101. PubMed ID: 3345775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial defibrillation using temporary epicardial defibrillation stainless steel wire electrodes: studies in the canine sterile pericarditis model.
    Ortiz J; Sokoloski MC; Ayers GM; Cmolik BL; Niwano S; Geha AS; Waldo AL
    J Am Coll Cardiol; 1995 Nov; 26(5):1356-64. PubMed ID: 7594054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.